Breaking News1 year ago
Subcutaneous Nivolumab as Effective as IV for Renal Cell Carcinoma — With Much Faster Treatment Time
[ad_1] Subcutaneous formula slashes treatment time to under 5 minutes Broad impact seen for greater access to and experience with treatment Study has implications for treatment...
